CPT code 95925 denotes a short‑latency somatosensory evoked potential (SSEP) study of the upper limbs, a neurodiagnostic test that evaluates sensory pathways by stimulating peripheral nerves or skin sites and recording central nervous system responses. This code captures a technically focused electrophysiology procedure used across neurology, neurosurgery, and intraoperative monitoring contexts. Nationally, 95925 matters because SSEP testing contributes to diagnosis and perioperative monitoring for conditions affecting sensory conduction, influencing clinical decision‑making and resource use in outpatient and surgical settings.

Key payers included in this review are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for CPT code 95925, typical sites of service, common billing modifiers, and what to expect from payer coverage patterns. The publication summarizes typical use cases, outlines billing considerations, and highlights benchmarking and policy elements relevant to neurodiagnostic services. Where input data is incomplete, the text notes that specific fields are not available. The goal is to provide a clear, national‑level reference for clinicians, billing staff, and policy analysts who manage or evaluate SSEP services.